勘误：原发性浆液性卵巢癌中预处理时高CA125水平的预后相关性。
Erratum: Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer.
作者信息
Bachmann Robert, Brucker Sara, Stäbler Annette, Krämer Bernhard, Ladurner Ruth, Königsrainer Alfred, Wallwiener Diethelm, Bachmann Cornelia
出版信息
Mol Clin Oncol. 2021 Apr;14(4):85. doi: 10.3892/mco.2021.2247. Epub 2021 Feb 26.
Abstract
[This corrects the article DOI: 10.3892/mco.2020.2170.].
摘要
[本文更正了文章的数字对象标识符：10.3892/mco.2020.2170。]
相似文献
1
Erratum: Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer.勘误：原发性浆液性卵巢癌中预处理时高CA125水平的预后相关性。
Mol Clin Oncol. 2021 Apr;14(4):85. doi: 10.3892/mco.2021.2247. Epub 2021 Feb 26.
2
Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer.原发性浆液性卵巢癌患者治疗前CA125水平升高的预后相关性
Mol Clin Oncol. 2021 Jan;14(1):8. doi: 10.3892/mco.2020.2170. Epub 2020 Nov 12.
3
High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.高水平的预处理CA125与高级别浆液性卵巢癌患者生存率的提高相关。
J Ovarian Res. 2016 Jul 7;9(1):41. doi: 10.1186/s13048-016-0247-6.
4
Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.血清CA19-9和CA125水平与超声造影参数数据相结合有助于鉴别卵巢浆液性癌与卵巢恶性上皮性癌。
Medicine (Baltimore). 2018 Apr;97(16):e0358. doi: 10.1097/MD.0000000000010358.
5
Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.原发性上皮性卵巢癌患者术前几种血清肿瘤标志物的测定
Gynecol Obstet Invest. 1999;47(1):52-7. doi: 10.1159/000010062.
6
The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer.术前、系统治疗前 CA125 水平对高级别浆液性卵巢癌患者的预后价值。
Int J Gynaecol Obstet. 2018 Feb;140(2):247-252. doi: 10.1002/ijgo.12376. Epub 2017 Nov 26.
7
Placental type alkaline phosphatase tissue expression in ovarian serous carcinoma.胎盘型碱性磷酸酶在卵巢浆液性癌中的组织表达
Cancer Biomark. 2016;17(4):479-486. doi: 10.3233/CBM-160665.
8
Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801).术前血清 CA125 升高对低恶性潜能卵巢肿瘤的预后价值：一项多国合作研究（ANZGOG0801）。
Gynecol Oncol. 2012 Jul;126(1):36-40. doi: 10.1016/j.ygyno.2012.02.031. Epub 2012 Feb 24.
9
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.术前血浆肿瘤标志物 HE4 和 CA125 对上皮性卵巢癌患者卵巢癌死亡率的预测作用。
PLoS One. 2019 Jun 20;14(6):e0218621. doi: 10.1371/journal.pone.0218621. eCollection 2019.
10
The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma.CA125正常预处理水平（<35 U/mL）在上皮性卵巢癌中的意义。
Rambam Maimonides Med J. 2015 Jan 29;6(1):e0005. doi: 10.5041/RMMJ.10180. eCollection 2015 Jan.
引用本文的文献
1
Association of Tumor-Infiltrating Lymphocytes and Inflammation Status with Survival Outcome in Patients with High-Grade Serous Ovarian Carcinoma.高级别浆液性卵巢癌患者肿瘤浸润淋巴细胞及炎症状态与生存结局的相关性
Cancers (Basel). 2025 Jul 8;17(14):2269. doi: 10.3390/cancers17142269.
Zotero 插件